Intratech is developing the Booster™ spiral balloon device for the treatment of AMI patients
After the revascularization of the occluded artery, the Booster™ balloon is placed in the coronary sinus vein, and due to its unique spiral design, it increases the vascular pressure
This elevated pressure enhances blood perfusion into the affected myocardium, improving the patient’s cardiac function
Allowing continuous venous outflow
Redistribution of blood to the deprived myocardium
Improving microvascular perfusion
May enhance washout of deleterious agents
May induce release of vascular growth factors
No obstruction of side branches
Moshe Barel, MSc
Moshe has more than 15 years of experience in the medical device industry, having taken leadership roles within start-up companies and global corporates. Moshe is the founder and CEO of AccuLine and prior to that Moshe served in several companies – as the CEO of Intratech Medical, CEO at Sanolla, VP of Strategy at NovaSight, and business unit director at Lumenis and Johnson & Johnson. Moshe holds a BA in Economics AND Business Administration and an MSc in Business Administration – both from Tel-Aviv university.
Eran Hirszowicz, MSc
Founder & CTO
Eran is a seasoned entrepreneur and inventor in the medical devices industry, with a proven track record in establishing successful medical device companies, with products that are in use today. Prior to founding Intratech Medical, Eran was the founder and CEO of GTI group, a medical device powerhouse with 3 subsidiaries: GTI-Medical, GTI-MD & GTI-Gali Tech, catering to start-ups and multinational corporations with product development, manufacturing and assembly services across the globe for over 20 years in numerous industries. Eran was also the founder & CTO of AngioSlide and EndoCross, startup companies developing solutions in endovascular and cardiology.
After his military service as Chief Machinery officer in the Israeli Navy (discharge as a Major), Eran established a factory for the production of optical elements. Eran holds an B.Sc. in Physics from the Technion – the Israel Institute of Technology and an M.Sc. in Biophysics from Tel Aviv University. He holds 12 patents, with most implemented in existing products.
Prof. Giora Weisz, MD
Prof. Weisz is an interventional cardiologist at Columbia University Medical Center in New York, an associate professor of medicine at Columbia University College of Physicians & Surgeons and a faculty member at the Cardiovascular Research Foundation.
Prof. Weisz is an internationally recognized researcher focused on innovative technologies in cardiovascular medicine. He has pioneered the use of novel robotic-enhanced coronary interventions, navigation and positioning technologies. Prof. Weisz has been the Principal Investigator for dozens of clinical studies – notably, with Mediguide which led to FDA approval and immediate acquisition of St Jude for 320M USD. He also consulted for SyncRx, influencing the system design which later led to acquisition by Volcano. Prof. Weisz was also a PI for the First-in-Human trial for the CorPath system which led to FDA approval resulting in an acquisition by Siemens for 1.1B USD. Prof. Weisz has published hundreds of papers in the most prestigious peer-reviewed medical journals, and is the author of dozens of articles, book chapters and other publications. He is an associate director of TCT – the premier interventional cardiology conference, and is a regular faculty member for the most important international cardiovascular meetings. Prof. Weisz serves as a reviewer for dozens of leading scientific journals and conferences. Prof. Weisz also serves on the editorial board of leading journals.
Prof. Rafael Beyar
M.D., D.Sc., M.P.H
Professor Rafael Beyar is an interventional cardiologist, a biomedical engineer and innovator. He is the former director of Rambam Health Care Campus and former Dean of the Faculty of Medicine at the Technion.
Prof. Beyar currently serves as a General Partner at Alive Health Care Fund and is the co-founder of the ICI – Innovation in Cardiovascular Interventions, a leading international cardiovascular meeting. His research focuses on cardiovascular robotics and imaging and coronary stents. He is the author of over 230 scientific publications and 15 books, is the recipient of numerous national and international awards and is the owner of multiple patents. Prof. Beyar founded Instent (acquired by Medtronic), Corindus (Acquired by Siemens), Rambam MedTech and MindUp Incubator (together with IBM, Medtronic, Pitango & Impact First), and serves as director and advisor for several start-up companies.
Dr. Timothy Henry
Dr. Timothy D. Henry is the Medical Director of The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital in Cincinnati, Ohio, and the President of SCAI – The Society for Cardiovascular Angiography and Interventions. Prior to The Lindner Research Center, he was the Chief of Cardiology at Smidt Heart Institute at Cedars Sinai Medical Center and a Professor of Medicine at Cedars-Sinai and UCLA and the Director of Research at the Minneapolis Heart Institute Foundation, at Abbott Northwestern Hospital in Minneapolis and a Professor of Medicine at the University of Minneapolis.
Dr. Henry published over 600 manuscripts and book chapters and has served as principal investigator and steering committees of multiple large, multicenter research trials in acute myocardial infarction, refractory angina, and regenerative medicine with gene and stem cell therapy. He is the Principle Investigator for 2 large STEMI registries, The Midwest STEMI Consortium and the North American COVID STEMI registry. Among other awards, Dr. Henry has been named to the Best Doctors in America list each year for the last 15 years, received the American Heart Association’s Heart and Stroke Hero Award in Research, the LUMEN Global Lifetime Achievement Award in Myocardial Infarction, and most recently was awarded the Cincinnati 2021 Health Care Heroes Award, Innovator.
Shefayim Commercial Center
Kibbutz Shefayim, 6099000